British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom;
British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
J Nucl Med. 2023 Sep;64(9):1478-1486. doi: 10.2967/jnumed.122.264331. Epub 2023 Aug 17.
Coronary F-sodium fluoride (F-fluoride) uptake is a marker of both atherosclerotic disease activity and disease progression. It is currently unknown whether there are rapid temporal changes in coronary F-fluoride uptake and whether these are more marked in those with clinically unstable coronary artery disease. This study aimed to determine the natural history of coronary F-fluoride uptake over 12 mo in patients with either advanced chronic coronary artery disease or a recent myocardial infarction. Patients with established multivessel coronary artery disease and either chronic disease or a recent acute myocardial infarction underwent coronary F-fluoride PET and CT angiography, which was repeated at 3, 6, or 12 mo. Coronary F-fluoride uptake was assessed in each vessel by measuring the coronary microcalcification activity (CMA). Coronary calcification was quantified by measuring calcium score, mass, and volume. Fifty-nine patients had chronic coronary artery disease (median age, 68 y; 93% male), and 52 patients had a recent myocardial infarction (median age, 65 y; 83% male). Reflecting the greater burden of coronary artery disease, baseline CMA values were higher in those with chronic coronary artery disease. Coronary F-fluoride uptake (CMA > 0) was associated with higher baseline calcium scores (294 Agatston units [AU] [interquartile range, 116-483 AU] vs. 72 AU [interquartile range, 8-222 AU]; < 0.001) and more rapid progression of coronary calcification scores (39 AU [interquartile range, 10-82 AU] vs. 12 AU [interquartile range, 1-36 AU]; < 0.001) than was the absence of uptake (CMA = 0). Coronary F-fluoride uptake did not markedly alter over the course of 3, 6, or 12 mo in patients with either chronic coronary artery disease or a recent myocardial infarction. Coronary F-fluoride uptake is associated with the severity and progression of coronary artery disease but does not undergo a rapid dynamic change in patients with chronic or unstable coronary artery disease. This finding suggests that coronary F-fluoride uptake is a temporally stable marker of established and progressive disease.
冠状动脉 F-氟化物(F-氟化物)摄取是动脉粥样硬化疾病活动和进展的标志物。目前尚不清楚冠状动脉 F-氟化物摄取是否存在快速的时间变化,以及在有临床不稳定冠状动脉疾病的患者中是否更为明显。本研究旨在确定在患有晚期慢性冠状动脉疾病或近期心肌梗死的患者中,冠状动脉 F-氟化物摄取在 12 个月内的自然史。患有多支血管冠状动脉疾病且患有慢性疾病或近期急性心肌梗死的患者接受冠状动脉 F-氟化物 PET 和 CT 血管造影检查,并在 3、6 或 12 个月时重复进行检查。通过测量冠状动脉微钙化活性(CMA)评估每个血管的冠状动脉 F-氟化物摄取。通过测量钙评分、质量和体积来量化冠状动脉钙化。59 例患者患有慢性冠状动脉疾病(中位年龄 68 岁;93%为男性),52 例患者患有近期心肌梗死(中位年龄 65 岁;83%为男性)。反映出冠状动脉疾病的负担更大,慢性冠状动脉疾病患者的基线 CMA 值更高。冠状动脉 F-氟化物摄取(CMA > 0)与更高的基线钙评分相关(294 个 Agatston 单位[AU] [四分位间距,116-483 AU] vs. 72 AU [四分位间距,8-222 AU];< 0.001)和更快速的冠状动脉钙化评分进展(39 AU [四分位间距,10-82 AU] vs. 12 AU [四分位间距,1-36 AU];< 0.001)比摄取缺失(CMA = 0)更为显著。在患有慢性冠状动脉疾病或近期心肌梗死的患者中,在 3、6 或 12 个月的过程中,冠状动脉 F-氟化物摄取并没有明显改变。冠状动脉 F-氟化物摄取与冠状动脉疾病的严重程度和进展相关,但在患有慢性或不稳定冠状动脉疾病的患者中不会发生快速的动态变化。这一发现表明,冠状动脉 F-氟化物摄取是已建立和进行性疾病的一个具有时间稳定性的标志物。